211 related articles for article (PubMed ID: 19278961)
21. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
22. Targeting mTOR signaling in lung cancer.
Marinov M; Fischer B; Arcaro A
Crit Rev Oncol Hematol; 2007 Aug; 63(2):172-82. PubMed ID: 17540577
[TBL] [Abstract][Full Text] [Related]
23. New agents in development for breast cancer.
Gao XP; Liu F
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):68-74. PubMed ID: 17218855
[TBL] [Abstract][Full Text] [Related]
24. Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.
Chinnaiyan P; Allen GW; Harari PM
Semin Radiat Oncol; 2006 Jan; 16(1):59-64. PubMed ID: 16378908
[TBL] [Abstract][Full Text] [Related]
25. Novel anticancer drug discovery.
Buolamwini JK
Curr Opin Chem Biol; 1999 Aug; 3(4):500-9. PubMed ID: 10419854
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
27. Novel targets for anticancer treatment development in colorectal cancer.
Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
[TBL] [Abstract][Full Text] [Related]
28. Novel agents and future directions for refractory breast cancer.
Burstein HJ
Semin Oncol; 2011 Jun; 38 Suppl 2():S17-24. PubMed ID: 21600381
[TBL] [Abstract][Full Text] [Related]
29. Novel therapeutic targets.
Farley J; Birrer MJ
Cancer Treat Res; 2009; 149():63-84. PubMed ID: 19763431
[No Abstract] [Full Text] [Related]
30. Novel therapeutic targets for multiple myeloma.
Mahindra A; Cirstea D; Raje N
Future Oncol; 2010 Mar; 6(3):407-18. PubMed ID: 20222797
[TBL] [Abstract][Full Text] [Related]
31. The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology.
Pollak M
Clin Cancer Res; 2012 Jan; 18(1):40-50. PubMed ID: 22215905
[TBL] [Abstract][Full Text] [Related]
32. Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs.
Garg D; Henrich S; Salo-Ahen OM; Myllykallio H; Costi MP; Wade RC
J Med Chem; 2010 Sep; 53(18):6539-49. PubMed ID: 20527892
[No Abstract] [Full Text] [Related]
33. Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models?
Damia G; D'Incalci M
Eur J Cancer; 2009 Nov; 45(16):2768-81. PubMed ID: 19762228
[TBL] [Abstract][Full Text] [Related]
34. [Recent update of molecular targeted therapy in pancreatic cancer].
Cho JH
Korean J Gastroenterol; 2013 Mar; 61(3):147-54. PubMed ID: 23575233
[TBL] [Abstract][Full Text] [Related]
35. Promising molecular targeted therapies in breast cancer.
Munagala R; Aqil F; Gupta RC
Indian J Pharmacol; 2011 May; 43(3):236-45. PubMed ID: 21713084
[TBL] [Abstract][Full Text] [Related]
36. Targeted therapy: an evolving concept in esophageal adenocarcinoma.
Gibson MK; Malhotra U
Oncology (Williston Park); 2010 Nov; 24(12):1143, 1146, 1148. PubMed ID: 21141696
[No Abstract] [Full Text] [Related]
37. The potential of Src inhibitors.
Elias D; Ditzel HJ
Aging (Albany NY); 2015 Oct; 7(10):734-5. PubMed ID: 26454527
[No Abstract] [Full Text] [Related]
38. Hallmarks of cancer: the next generation.
Hanahan D; Weinberg RA
Cell; 2011 Mar; 144(5):646-74. PubMed ID: 21376230
[TBL] [Abstract][Full Text] [Related]
39. Primary structure polymorphism at amino acid residue 72 of human p53.
Matlashewski GJ; Tuck S; Pim D; Lamb P; Schneider J; Crawford LV
Mol Cell Biol; 1987 Feb; 7(2):961-3. PubMed ID: 3547088
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
Graham FL; Smiley J; Russell WC; Nairn R
J Gen Virol; 1977 Jul; 36(1):59-74. PubMed ID: 886304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
